Evaluation of the contemporary occurrence rates of metallo-β-lactamases in multidrug-resistant Gram-negative bacilli in Japan: Report from the SENTRY Antimicrobial Surveillance Program (1998–2002)
- 31 August 2004
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 49 (4), 289-294
- https://doi.org/10.1016/j.diagmicrobio.2004.04.007
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Endemic Carbapenem-resistantPseudomonas aeruginosawith Acquired Metallo-β-lactamase Determinants in European HospitalEmerging Infectious Diseases, 2004
- Clinical and Bacteriological Characteristics of IMP-Type Metallo-β-Lactamase-Producing Pseudomonas aeruginosaClinical Infectious Diseases, 2003
- IMP-12, a New Plasmid-Encoded Metallo-β-Lactamase from a Pseudomonas putida Clinical IsolateAntimicrobial Agents and Chemotherapy, 2003
- Trends in Antimicrobial-Drug Resistance in JapanEmerging Infectious Diseases, 2000
- Convenient Test for Screening Metallo-β-Lactamase-Producing Gram-Negative Bacteria by Using Thiol CompoundsJournal of Clinical Microbiology, 2000
- In vitro evaluation of cefepime and other broad-spectrum β-lactams in 22 medical centers in Japan: a phase II trial comparing two annual organism samplesDiagnostic Microbiology and Infectious Disease, 1999
- Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical IsolateAntimicrobial Agents and Chemotherapy, 1999
- Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in JapanDiagnostic Microbiology and Infectious Disease, 1999
- Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescensAntimicrobial Agents and Chemotherapy, 1995
- In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitorAntimicrobial Agents and Chemotherapy, 1989